TCI Wealth Advisors’s Neuronetics STIM Stock Holding History

TCI Wealth Advisors’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-21	Closed	–	–	1544
2019 Q1	$0	Buy	+21	New	+$347	﹤0.01%	1546

Other funds holding STIM

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCI Wealth Advisors's STIM Position: Q2 2019 in Review

TCI Wealth Advisors sold out of Neuronetics (STIM) in Q2 2019, closing a stake of 21 shares.

TCI Wealth Advisors first reported a position in STIM in Q1 2019 and held it in 1 quarter. The position peaked at $0 in Q1 2019. 59 funds tracked by Wall St. Rank hold STIM as of Q2 2019.

TCI Wealth Advisors reported no remaining Neuronetics position as of Q2 2019 after selling out during the quarter.
TCI Wealth Advisors sold 21 Neuronetics shares in Q2 2019.
TCI Wealth Advisors first reported a position in Neuronetics in Q1 2019 and held it in 1 quarter.
TCI Wealth Advisors's Neuronetics position peaked at $0 in Q1 2019.
59 funds tracked by Wall St. Rank held Neuronetics as of Q2 2019.

Based on TCI Wealth Advisors's 13F filing for Q2 2019, filed 23 Jul 2019.